VRQ-15957-10285
4 vaccinations
3 coded responses
46 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 920 / CA
- Registered
- 2021-02-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
DVG-31536-97188
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-01-29
Dose 1 — Moderna
-
2021-02-08
Registered in v-safe
-
2021-02-08
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-12
- 2021-02-20
-
2021-02-26
Dose 2 — Moderna
- 2021-02-26
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-05-28
- 2021-08-27
-
2021-11-17
Dose 3 — Moderna
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-12-01
- 2021-12-10
- 2021-12-15
- 2021-12-22
- 2021-12-29
-
2022-02-18
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: I'm pregnantMedDRA releases: 2024-11 · check-in free text available
- 2022-05-20
-
2022-11-19
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Had 2-3 colds in the last 2 monthsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Dose 4 — Pfizer-BioNTech
- 2022-12-09
-
2022-12-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-12-11
- 2022-12-12
- 2022-12-15
- 2022-12-16
- 2022-12-23
- 2022-12-30
- 2023-01-06
- 2023-01-13
- 2023-01-22
-
2023-03-10
Survey response — 3 months, dose 4MedDRA: Influenza, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-06-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-02-26 | Moderna | |
| 3 | 2021-11-17 | Moderna | No |
| 4 | 2022-12-09 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: I'm pregnant
Release 12 — 12 months, dose 3
Symptoms: Had 2-3 colds in the last 2 months
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release